Nicole D. Wagner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicole D. Wagner has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Michael L. Gross
Washington University in St. Louis
12 shared publications - David H. Russell
Texas A&M University
6 shared publications - Austin B. Moyle
Washington University in St. Louis
5 shared publications - Daisy W. Leung
Department of Medicine, Washington University School of Medicine
5 shared publications - Gaya K. Amarasinghe
Department of Pathology and Immunology, Washington University School of Medicine
3 shared publications - Aidan R. Cole
Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
2 shared publications
Latest Publications
- 21 May 2026
- Published by Elsevier in Journal of Molecular Biology
- Vol. 438 (17) , 169875
Biophysical Characterization of Ebola VP35 Protein Binding to Host Mindbomb Protein 2
- 21 May 2026
- Published by Elsevier in Journal of Molecular Biology
- Vol. 438 (17) , 169875
Biophysical Characterization of Ebola VP35 Protein Binding to Host Mindbomb Protein 2
- 30 May 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (23) , 9693-9703
Evaluating Chemical Footprinting-Induced Perturbation of Protein Higher Order Structure
Specific amino acid footprinting mass spectrometry (MS) is an increasingly utilized method for elucidating protein higher order structure (HOS). It does this by adding to certain amino acid residues a mass tag, whose reaction extent depends on solvent accessibility and microenvironment of the protein. Unlike reactive free radicals and carbenes, these specific footprinters react slower than protein unfolding. Thus, their footprinting, under certain conditions, provokes structural changes to the protein, leading to labeling on non-native structures. It is critical to establish conditions (i.e., reagent concentrations, time of reaction) to ensure that the structure of the protein following footprinting remains native. Here, we compare the efficacy of five methods in assessing protein HOS following footprinting at the intact protein level and then further localize the perturbation at the peptide level. Three are MS-based methods that provide dose-response plot analysis, evaluation of Poisson distributions of precursor and products, and determination of the average number of modifications. These MS-based methods reliably and effectively indicate HOS perturbation at the intact protein level, whereas spectroscopic methods (circular dichroism (CD) and dynamic light scattering (DLS)) are less sensitive in monitoring subtle HOS perturbation caused by footprinting. Evaluation of HOS at the peptide level indicates regions that are sensitive to localized perturbations. Peptide-level analysis also provides higher resolution of the HOS perturbation, and we recommend using it for future footprinting studies. Overall, this work shows conclusive evidence for HOS perturbation caused by footprinting. Implementation of quality control workflows can identify conditions to avoid the perturbation, for footprinting, allowing accurate and reliable identification of protein structural changes that accompany, for example, ligand interactions, mutations, and changes in solution environment.
- 30 May 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (23) , 9693-9703
Evaluating Chemical Footprinting-Induced Perturbation of Protein Higher Order Structure
Specific amino acid footprinting mass spectrometry (MS) is an increasingly utilized method for elucidating protein higher order structure (HOS). It does this by adding to certain amino acid residues a mass tag, whose reaction extent depends on solvent accessibility and microenvironment of the protein. Unlike reactive free radicals and carbenes, these specific footprinters react slower than protein unfolding. Thus, their footprinting, under certain conditions, provokes structural changes to the protein, leading to labeling on non-native structures. It is critical to establish conditions (i.e., reagent concentrations, time of reaction) to ensure that the structure of the protein following footprinting remains native. Here, we compare the efficacy of five methods in assessing protein HOS following footprinting at the intact protein level and then further localize the perturbation at the peptide level. Three are MS-based methods that provide dose-response plot analysis, evaluation of Poisson distributions of precursor and products, and determination of the average number of modifications. These MS-based methods reliably and effectively indicate HOS perturbation at the intact protein level, whereas spectroscopic methods (circular dichroism (CD) and dynamic light scattering (DLS)) are less sensitive in monitoring subtle HOS perturbation caused by footprinting. Evaluation of HOS at the peptide level indicates regions that are sensitive to localized perturbations. Peptide-level analysis also provides higher resolution of the HOS perturbation, and we recommend using it for future footprinting studies. Overall, this work shows conclusive evidence for HOS perturbation caused by footprinting. Implementation of quality control workflows can identify conditions to avoid the perturbation, for footprinting, allowing accurate and reliable identification of protein structural changes that accompany, for example, ligand interactions, mutations, and changes in solution environment.
- 3 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (741) , eadj9052
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
Microglia help limit the progression of Alzheimer’s disease (AD) by constraining amyloid-β (Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals delivered by distinct cell surface receptors. Human leukocyte Ig-like receptor B4 (LILRB4) is an inhibitory receptor of the immunoglobulin (Ig) superfamily that is expressed on myeloid cells and recognizes apolipoprotein E (ApoE) among other ligands. Here, we find that LILRB4 is highly expressed in the microglia of patients with AD. Using mice that accumulate Aβ and carry a transgene encompassing a portion of the LILR region that includes LILRB4 , we corroborated abundant LILRB4 expression in microglia wrapping around Aβ plaques. Systemic treatment of these mice with an anti-human LILRB4 monoclonal antibody (mAb) reduced Aβ load, mitigated some Aβ-related behavioral abnormalities, enhanced microglia activity, and attenuated expression of interferon-induced genes. In vitro binding experiments established that human LILRB4 binds both human and mouse ApoE and that anti-human LILRB4 mAb blocks such interaction. In silico modeling, biochemical, and mutagenesis analyses identified a loop between the two extracellular Ig domains of LILRB4 required for interaction with mouse ApoE and further indicated that anti-LILRB4 mAb may block LILRB4-mApoE by directly binding this loop. Thus, targeting LILRB4 may be a potential therapeutic avenue for AD.
- 3 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (741) , eadj9052
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
Microglia help limit the progression of Alzheimer’s disease (AD) by constraining amyloid-β (Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals delivered by distinct cell surface receptors. Human leukocyte Ig-like receptor B4 (LILRB4) is an inhibitory receptor of the immunoglobulin (Ig) superfamily that is expressed on myeloid cells and recognizes apolipoprotein E (ApoE) among other ligands. Here, we find that LILRB4 is highly expressed in the microglia of patients with AD. Using mice that accumulate Aβ and carry a transgene encompassing a portion of the LILR region that includes LILRB4 , we corroborated abundant LILRB4 expression in microglia wrapping around Aβ plaques. Systemic treatment of these mice with an anti-human LILRB4 monoclonal antibody (mAb) reduced Aβ load, mitigated some Aβ-related behavioral abnormalities, enhanced microglia activity, and attenuated expression of interferon-induced genes. In vitro binding experiments established that human LILRB4 binds both human and mouse ApoE and that anti-human LILRB4 mAb blocks such interaction. In silico modeling, biochemical, and mutagenesis analyses identified a loop between the two extracellular Ig domains of LILRB4 required for interaction with mouse ApoE and further indicated that anti-LILRB4 mAb may block LILRB4-mApoE by directly binding this loop. Thus, targeting LILRB4 may be a potential therapeutic avenue for AD.
- 23 June 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (26) , 10119-10126
Workflow for Validating Specific Amino Acid Footprinting Reagents for Protein Higher Order Structure Elucidation
Protein footprinting mass spectrometryprobes protein higher orderstructure and dynamics by labeling amino acid side-chains or backboneamides as a function of solvent accessibility. One category of footprintinguses residue-specific, irreversible covalent modifications, affordingflexibility of sample processing for bottom-up analysis. Althoughseveral specific amino acid footprinting technologies are becomingestablished in structural proteomics, there remains a need to assessfundamental properties of new reagents before their application. Often,footprinting reagents are applied to complex or novel protein systemssoon after their discovery and sometimes without a thorough investigationof potential downsides of the reagent. In this work, we assemble andtest a validation workflow that utilizes cyclic peptides and a modelprotein to characterize benzoyl fluoride, a recently published, next-generationnucleophile footprinter. The workflow includes the characterizationof potential side-chain reactive groups, reaction "quench"efficacies, reagent considerations and caveats (e.g., buffer pH),residue-specific kinetics compared to those of established reagents,and protein-wide characterization of modification sites with considerationsfor proteolysis. The proposed workflow serves as a starting pointfor improved footprinting reagent discovery, validation, and introduction,the aspects of which we recommend before applying to unknown proteinsystems.
- 23 June 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (26) , 10119-10126
Workflow for Validating Specific Amino Acid Footprinting Reagents for Protein Higher Order Structure Elucidation
Protein footprinting mass spectrometryprobes protein higher orderstructure and dynamics by labeling amino acid side-chains or backboneamides as a function of solvent accessibility. One category of footprintinguses residue-specific, irreversible covalent modifications, affordingflexibility of sample processing for bottom-up analysis. Althoughseveral specific amino acid footprinting technologies are becomingestablished in structural proteomics, there remains a need to assessfundamental properties of new reagents before their application. Often,footprinting reagents are applied to complex or novel protein systemssoon after their discovery and sometimes without a thorough investigationof potential downsides of the reagent. In this work, we assemble andtest a validation workflow that utilizes cyclic peptides and a modelprotein to characterize benzoyl fluoride, a recently published, next-generationnucleophile footprinter. The workflow includes the characterizationof potential side-chain reactive groups, reaction "quench"efficacies, reagent considerations and caveats (e.g., buffer pH),residue-specific kinetics compared to those of established reagents,and protein-wide characterization of modification sites with considerationsfor proteolysis. The proposed workflow serves as a starting pointfor improved footprinting reagent discovery, validation, and introduction,the aspects of which we recommend before applying to unknown proteinsystems.
- 13 July 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (29) , 10314-10319
Automated Specific Amino Acid Footprinting Mass Spectrometry: Repurposing an HDX Platform for Determining Reagent Feasibility
Protein footprinting is a mass spectrometry (MS)-based approach to measure protein conformational changes. One approach, specific amino acid labeling, imparts often an irreversible modification to protein side chains but requires careful selection of the reactive reagent and often time-consuming optimization of experimental parameters prior to submission to bottom-up MS analysis. In this work, we repurpose a hydrogen-deuterium exchange MS (HDX-MS) LEAP HDX system for automated specific amino acid footprinting MS, demonstrating its efficacy in reaction optimization and monitoring applicability to specific ligand binding systems. We screened reagent conditions for two model ligand-binding systems and demonstrate the method's efficacy for measuring differences induced by ligand binding. Our proof-of-concept experiments provide a platform for rapidly screening specific amino acid reagents and reaction conditions for protein systems to be studied by footprinting.
- 13 July 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (29) , 10314-10319
Automated Specific Amino Acid Footprinting Mass Spectrometry: Repurposing an HDX Platform for Determining Reagent Feasibility
Protein footprinting is a mass spectrometry (MS)-based approach to measure protein conformational changes. One approach, specific amino acid labeling, imparts often an irreversible modification to protein side chains but requires careful selection of the reactive reagent and often time-consuming optimization of experimental parameters prior to submission to bottom-up MS analysis. In this work, we repurpose a hydrogen-deuterium exchange MS (HDX-MS) LEAP HDX system for automated specific amino acid footprinting MS, demonstrating its efficacy in reaction optimization and monitoring applicability to specific ligand binding systems. We screened reagent conditions for two model ligand-binding systems and demonstrate the method's efficacy for measuring differences induced by ligand binding. Our proof-of-concept experiments provide a platform for rapidly screening specific amino acid reagents and reaction conditions for protein systems to be studied by footprinting.
- 12 January 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (3) , 1520-1524
Benzoyl Transfer for Footprinting Alcohol-Containing Residues in Higher Order Structural Applications of Mass-Spectrometry-Based Proteomics
Protein footprinting mass spectrometry (MS), an emerging approach to elucidate higher-order structure (HOS) and binding, benefits from the iterative development of reaction strategies to expand the covalent labeling toolbox. Herein, we introduce a footprinting reagent for nucleophiles and demonstrate its efficacy for differential covalent labeling MS analysis. Benzoyl fluoride (BF), although reactive with water, is more practical for modifying nucleophilic functional groups than other acid halides and serves as an acyl-transfer reagent for proteins. BF is 10 times more reactive with phenolic Tyr than the current generation nucleophile footprinter. BF modifies, in addition to Tyr, Lys, His, and the N-terminus, weak nucleophiles Ser and Thr, for which few footprinters exist, imparting broad applicability with a range of nucleophiles. We applied benzoylation to a model Ser- and Thr-rich protein–ligand binding system without perturbing the protein HOS. This efficacious footprinting method expands the toolbox of reagents and provides promise for future reaction strategies including possibly membrane proteins.
- 12 January 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (3) , 1520-1524
Benzoyl Transfer for Footprinting Alcohol-Containing Residues in Higher Order Structural Applications of Mass-Spectrometry-Based Proteomics
Protein footprinting mass spectrometry (MS), an emerging approach to elucidate higher-order structure (HOS) and binding, benefits from the iterative development of reaction strategies to expand the covalent labeling toolbox. Herein, we introduce a footprinting reagent for nucleophiles and demonstrate its efficacy for differential covalent labeling MS analysis. Benzoyl fluoride (BF), although reactive with water, is more practical for modifying nucleophilic functional groups than other acid halides and serves as an acyl-transfer reagent for proteins. BF is 10 times more reactive with phenolic Tyr than the current generation nucleophile footprinter. BF modifies, in addition to Tyr, Lys, His, and the N-terminus, weak nucleophiles Ser and Thr, for which few footprinters exist, imparting broad applicability with a range of nucleophiles. We applied benzoylation to a model Ser- and Thr-rich protein–ligand binding system without perturbing the protein HOS. This efficacious footprinting method expands the toolbox of reagents and provides promise for future reaction strategies including possibly membrane proteins.
- Open Access
- 8 December 2021
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (1) , 118-128
Nipah Virus V Protein Binding Alters MDA5 Helicase Folding Dynamics
Nipah virus (NiV) is an emerging and deadly zoonotic paramyxovirus that is responsible for periodic epidemics of acute respiratory illness and encephalitis in humans. Previous studies have shown that the NiV V protein antagonizes host antiviral immunity, but the molecular mechanism is incompletely understood. To address this gap, we biochemically characterized NiV V binding to the host pattern recognition receptor MDA5. We find that the C-terminal domain of NiV V (VCTD) is sufficient to bind the MDA5SF2 domain when recombinantly co-expressed in bacteria. Analysis by hydrogen–deuterium exchange mass spectrometry (HDX-MS) studies revealed that NiV VCTD is conformationally dynamic, and binding to MDA5 reduces the dynamics of VCTD. Our results also suggest that the β-sheet region in between the MDA5 Hel1, Hel2, and Hel2i domains exhibits rapid HDX. Upon VCTD binding, these β-sheet and adjacent residues show significant protection. Collectively, our findings suggest that NiV V binding disrupts the helicase fold and dynamics of MDA5 to antagonize host antiviral immunity.
- 8 December 2021
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 8 (1) , 118-128
Open AccessNipah Virus V Protein Binding Alters MDA5 Helicase Folding Dynamics
Nipah virus (NiV) is an emerging and deadly zoonotic paramyxovirus that is responsible for periodic epidemics of acute respiratory illness and encephalitis in humans. Previous studies have shown that the NiV V protein antagonizes host antiviral immunity, but the molecular mechanism is incompletely understood. To address this gap, we biochemically characterized NiV V binding to the host pattern recognition receptor MDA5. We find that the C-terminal domain of NiV V (VCTD) is sufficient to bind the MDA5SF2 domain when recombinantly co-expressed in bacteria. Analysis by hydrogen–deuterium exchange mass spectrometry (HDX-MS) studies revealed that NiV VCTD is conformationally dynamic, and binding to MDA5 reduces the dynamics of VCTD. Our results also suggest that the β-sheet region in between the MDA5 Hel1, Hel2, and Hel2i domains exhibits rapid HDX. Upon VCTD binding, these β-sheet and adjacent residues show significant protection. Collectively, our findings suggest that NiV V binding disrupts the helicase fold and dynamics of MDA5 to antagonize host antiviral immunity.
- Open Access
- 7 October 2021
- Published by Elsevier in STAR Protocols
- Vol. 2 (4) , 100906
Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
- 7 October 2021
- Published by Elsevier in STAR Protocols
- Vol. 2 (4) , 100906
Open AccessDomain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
- 2 June 2021
- Published by Elsevier in Cell Chemical Biology
- Vol. 28 (10) , 1528-1538.e4
Native mass spectrometry and gas-phase fragmentation provide rapid and in-depth topological characterization of a PROTAC ternary complex
- 2 June 2021
- Published by Elsevier in Cell Chemical Biology
- Vol. 28 (10) , 1528-1538.e4
Native mass spectrometry and gas-phase fragmentation provide rapid and in-depth topological characterization of a PROTAC ternary complex
- 9 March 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (10)
Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2
Significance: The human respiratory syncytial virus (RSV) is a significant cause of lower respiratory tract infections in the young and the elderly and a substantial burden to global human health. Currently, there are no specific and effective treatments for RSV infections. Here we report the first X-ray crystal structure of RSV nonstructural protein 2 (NS2), which revealed a unique fold. The combined biochemical and structural analyses of the NS2 structure identified a region that binds to and inhibits ubiquitination of an inactive form of RIG-I and MDA5, preventing downstream signaling and type I interferon production. Our study provides structural insight into the mechanism of how NS2 antagonizes IFN response to RSV infection and defines a target for antiviral development.
- 9 March 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (10)
Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2
Significance: The human respiratory syncytial virus (RSV) is a significant cause of lower respiratory tract infections in the young and the elderly and a substantial burden to global human health. Currently, there are no specific and effective treatments for RSV infections. Here we report the first X-ray crystal structure of RSV nonstructural protein 2 (NS2), which revealed a unique fold. The combined biochemical and structural analyses of the NS2 structure identified a region that binds to and inhibits ubiquitination of an inactive form of RIG-I and MDA5, preventing downstream signaling and type I interferon production. Our study provides structural insight into the mechanism of how NS2 antagonizes IFN response to RSV infection and defines a target for antiviral development.